Results 161 to 170 of about 9,804 (228)

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons. [PDF]

Antimicrob Agents Chemother, 2016
Lahser FC, Bystol K, Curry S, McMonagle P, Xia E, Ingravallo P, Chase R, Liu R, Black T, Hazuda D, Howe AY, Asante-Appiah E.   +11 more
europepmc   +1 more source

Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt. [PDF]

Int J Mol Sci
Garcia-Cehic D, Mosbeh A, A Gad H, Gomaa AI, Ibañez Lligoña M, Gregori J, Colomer-Castell S, Campos C, Rodriguez-Frias F, Esteban JI, Kohla MS, Abdel-Rahman MH, Quer J.   +12 more
europepmc   +1 more source

Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885. [PDF]

Antimicrob Agents Chemother, 2013
Wong KA, Worth A, Martin R, Svarovskaia E, Brainard DM, Lawitz E, Miller MD, Mo H.   +7 more
europepmc   +1 more source

Genetic Characterization of Hepatitis C Virus Among People Who Use Crack Cocaine: A Study Conducted on the Brazilian Amazon Coast. [PDF]

Pathogens
Heymbeeck JAA, do Nascimento WL, Freitas MCS, de Sousa Rocha L, Costa FF, de Queiroz JPQ, Simeone D, Martins LC, Machado LFA, Fischer B, Kupek E, Oliveira-Filho AB.   +11 more
europepmc   +1 more source

Effect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvir. [PDF]

Antimicrob Agents Chemother, 2012
Pelosi LA, Voss S, Liu M, Gao M, Lemm JA.   +4 more
europepmc   +1 more source

A Quinoline Derivative HZ-6d Induces Antiviral Activity Against Hepatitis C Virus Via Apoptosis-Mediated Cytotoxicity. [PDF]

Kobe J Med Sci
Suwardana GNR, Rhamadianti AF, Abe T, Deng L, Matsui C, Yasui M, Takeda N, Yamada T, Ueda M, Shoji I.   +9 more
europepmc   +1 more source

Characteristics of a Chinese Cohort of Patients with Chronic Hepatitis C Infection (2019-2023) and a Case Report of Resistance-associated Substitutions to Sofosbuvir-velpatasvir Treatment. [PDF]

J Clin Transl Hepatol
Xiong H, Pan S, Zhou C, Shi H, Xie Y, Guo J.   +5 more
europepmc   +1 more source

Protein tyrosine kinase Src suppresses hepatitis C virus particle release through regulation of Ndrg1. [PDF]

J Biol Chem
Fu L, Takeuchi K, Chihara K, Feng W, Sada K.   +4 more
europepmc   +1 more source

Echocardiogram study to evaluate the effect of the novel hepatitis C virus NS5A inhibitor GSK2336805 on cardiac contractility in healthy subjects. [PDF]

Antimicrob Agents Chemother, 2013
Wilfret DA, Adkison KK, Jones LA, Lou Y, Gan J, Spreen W.   +5 more
europepmc   +1 more source

A Bibliometric Analysis of the HCV Drug-Resistant Majority and Minority Variants. [PDF]

Int J Environ Res Public Health
Immanuel OM, Fabiyi OT, Oshakbayev KP, Abuova G, Konysbekova A, Vattipally SB, Ali S, Abidi SH.   +7 more
europepmc   +1 more source